Compass Pathways PLC’s stock is set to debut Friday, after the U.K.-based mental health care company’s upsized initial public offering price at $17 a share, above the expected range of between $14 and $16 a share. The company sold 7.5 million American depositary shares (ADS) in the IPO, up from previous expectations of 6.7 million ADS, to raise $127.5 million. The pricing values the company at around $578.1 million. The stock is slated to start trading on the Nasdaq exchange under the ticker symbol “CMPS.” The company is looking to go public at a time that the Renaissance IPO ETF has rallied 20.5% over the past three months, while the S&P 500 has gained 7.7%.